Healthcare Triangle, Inc.
HCTI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | 0.02 | -0.01 | 0.02 |
| FCF Yield | -20.93% | -14.24% | -89.91% | -19.38% |
| EV / EBITDA | -2.02 | -3.53 | -1.28 | -13.85 |
| Quality | ||||
| ROIC | 192.82% | -211.91% | -61.17% | -24.57% |
| Gross Margin | 24.71% | 20.41% | 24.62% | 29.83% |
| Cash Conversion Ratio | 0.18 | 0.13 | 0.27 | 1.20 |
| Growth | ||||
| Revenue 3-Year CAGR | -36.60% | -1.99% | 13.55% | 7.07% |
| Free Cash Flow Growth | 33.48% | 72.55% | 42.20% | -1,293.96% |
| Safety | ||||
| Net Debt / EBITDA | -0.68 | -0.75 | -0.18 | -0.43 |
| Interest Coverage | -3.92 | -11.72 | -49.13 | -9.45 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -70.60 | 8.60 | 28.85 | 72.47 |